MARCELA GALLEGOS: Open Payments
NPI 1225431596 · LAREDO, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,019 in 86 payments from 10 companies in 2025. Trend: 2023 $870 · 2024 $1,777 · 2025 $2,019
Food & beverage: $1,820Education: $199
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 14 | $548 |
| Amgen Inc. | 19 | $378 |
| Novartis Pharmaceuticals Corporation | 13 | $308 |
| ABBVIE INC. | 12 | $223 |
| UCB, Inc. | 6 | $153 |
| Aurinia Pharma U.S., Inc. | 7 | $110 |
| AstraZeneca Pharmaceuticals LP | 5 | $107 |
| E.R. Squibb & Sons, L.L.C. | 5 | $86 |
| GlaxoSmithKline, LLC. | 4 | $80 |
| ANI Pharmaceuticals, Inc. | 1 | $25 |
Products named: TREMFYA, COSENTYX, ENBREL, Bimzelx, SKYRIZI, TAVNEOS, LUPKYNIS, SAPHNELO.
Industry payments across TX — which companies pay providers there.
